Taro Pharmaceutical Industries Ltd (TARO.N)
|Market Cap (Mil.):||$6,038.46|
|Shares Outstanding (Mil.):||42.83|
Reuters Market Eye - Shares of Sun Pharmaceutical Industries Ltd fall 0.9 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates.
* Shares of India's Sun Pharmaceutical Industries Ltd fall 0.8 percent after quarterly earnings at unit Taro Pharmaceutical Industries fail to beat some analyst estimates. * Taro's revenue in January-March grew by 13 percent to $187 million, while profit jumped by 82 percent to $90 million. * Sun Pharma is scheduled to report its Jan-March results on Thursday. (email@example.com / firstname.lastname@example.org)
MUMBAI - Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said.
|Ranbaxy Laboratories Limited (RANB.NS)||Rs586.05||-4.20|
|Pfizer Inc. (PFE.N)||$29.27||-0.20|
|Novartis AG (NOVN.VX)||CHF80.35||+0.35|
|Merck & Co., Inc. (MRK.N)||$57.91||-0.67|
|Bayer AG (BAYGn.DE)||€101.00||+1.52|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,425.00p||+6.00|
|Eli Lilly and Co (LLY.N)||$62.47||-0.30|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||18,790.00₪||+90.00|
|Bristol-Myers Squibb Co (BMY.N)||$50.98||-0.03|